Canopy Growth Corp (CGC)
3.94
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
3.94
0.00 (0.00%)
After-Hours: 20:00
Canopy Growth Price: 3.94 for Nov. 13, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 3.95 | 4.12 | 3.65 | 3.94 | 10.24M |
| Nov 12, 2024 | 4.01 | 4.38 | 3.86 | 3.94 | 13.88M |
| Nov 11, 2024 | 4.23 | 4.24 | 3.85 | 4.04 | 8.402M |
| Nov 08, 2024 | 4.50 | 4.54 | 4.08 | 4.24 | 6.501M |
| Nov 07, 2024 | 4.54 | 4.745 | 4.45 | 4.55 | 6.617M |
| Nov 06, 2024 | 4.40 | 4.59 | 4.15 | 4.41 | 13.50M |
| Nov 05, 2024 | 5.40 | 5.61 | 5.15 | 5.59 | 7.906M |
| Nov 04, 2024 | 5.12 | 5.80 | 5.07 | 5.49 | 13.25M |
| Nov 01, 2024 | 4.70 | 4.94 | 4.64 | 4.86 | 4.477M |
| Oct 31, 2024 | 4.93 | 4.98 | 4.57 | 4.59 | 3.791M |
| Oct 30, 2024 | 5.21 | 5.445 | 4.84 | 4.95 | 6.964M |
| Oct 29, 2024 | 5.33 | 5.72 | 5.20 | 5.25 | 6.290M |
| Oct 28, 2024 | 5.63 | 5.64 | 5.25 | 5.40 | 7.690M |
| Oct 25, 2024 | 4.95 | 5.545 | 4.93 | 5.44 | 11.14M |
| Oct 24, 2024 | 5.16 | 5.39 | 4.83 | 4.91 | 9.099M |
| Oct 23, 2024 | 4.875 | 5.27 | 4.80 | 5.04 | 11.64M |
| Oct 22, 2024 | 4.35 | 5.30 | 4.315 | 4.98 | 18.48M |
| Oct 21, 2024 | 4.45 | 4.49 | 4.27 | 4.34 | 2.630M |
| Oct 18, 2024 | 4.37 | 4.507 | 4.29 | 4.44 | 4.542M |
| Oct 17, 2024 | 4.25 | 4.325 | 4.17 | 4.31 | 2.362M |
| Oct 16, 2024 | 4.17 | 4.26 | 4.16 | 4.26 | 2.457M |
| Oct 15, 2024 | 4.22 | 4.23 | 4.06 | 4.13 | 2.331M |
| Oct 14, 2024 | 4.14 | 4.25 | 4.11 | 4.19 | 3.139M |
| Oct 11, 2024 | 3.97 | 4.14 | 3.91 | 4.04 | 4.474M |
| Oct 10, 2024 | 4.00 | 4.01 | 3.85 | 3.98 | 2.405M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.77
Minimum
Mar 14 2024
521.70
Maximum
Feb 10 2021
100.23
Average
54.85
Median
Price Benchmarks
| Tilray Brands Inc | 1.445 |
| Aurinia Pharmaceuticals Inc | 8.28 |
| Edesa Biotech Inc | 2.20 |
| Lexaria Bioscience Corp | 2.25 |
| Xenon Pharmaceuticals Inc | 41.92 |
Price Related Metrics
| PS Ratio | 1.617 |
| Price to Book Value | 1.100 |
| Earnings Yield | -119.4% |
| Market Cap | 415.12M |